Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

Objective: To evaluate the safety of in-home use of the MiniMed™ 670G system with SmartGuard™ technology in children with type 1 diabetes (T1D). Methods: Participants (N = 105, ages 7–13 years, mean age 10.8 ± 1.8 years) were enrolled at nine centers (eight in the United States and one in Israel) an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Technol Ther
Hlavní autoři: Forlenza, Gregory P., Pinhas-Hamiel, Orit, Liljenquist, David R., Shulman, Dorothy I., Bailey, Timothy S., Bode, Bruce W., Wood, Michael A., Buckingham, Bruce A., Kaiserman, Kevin B., Shin, John, Huang, Suiying, Lee, Scott W., Kaufman, Francine R.
Médium: Artigo
Jazyk:Inglês
Vydáno: Mary Ann Liebert, Inc., publishers 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350071/
https://ncbi.nlm.nih.gov/pubmed/30585770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0264
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky